Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

Published:2012-09-10 Issue:4 Volume:48 Page:557-561
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gertz M A,Lacy M Q,Dispenzieri A,Kumar S K,Dingli D,Leung N,Hogan W J,Buadi F K,Hayman S R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2012170.pdf

Reference35 articles.

1. Cohen AD, Comenzo RL . Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program 2010; 2010: 287–294.

2. Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK et al. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc 2011; 86: 12–18.

3. Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood 1996; 88: 2801–2806.

4. Palladini G, Russo P, Nuvolone M, Lavatelli F, Perfetti V, Obici L et al. Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis. Blood 2007; 110: 787–788.

5. Jaccard A, Moreau P, Leblond V, Leleu X, Benboubker L, Hermine O et al. Myélome Autogreffe (MAG) and Intergroupe Francophone du Myélome (IFM) Intergroup. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 2007; 357: 1083–1093.

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

2. Clinical Use of Biomarkers in Cardiac Amyloidosis;Heart Failure Clinics;2024-07

3. The Real-World Data on Patients With Cardiac Stage IIIb AL Amyloidosis;Clinical Lymphoma Myeloma and Leukemia;2024-05

4. Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management;Journal of Clinical Medicine;2024-03-18

5. Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis;JACC: CardioOncology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3